HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Comparison of cyclosporin A, verapamil, PSC-833 and cremophor EL as enhancing agents of VP-16 in murine lymphoid leukemias.

Abstract
Although verapamil, cyclosporin A. cremophor EL and PSC-833 are active as multidrug resistance modulators, there has been limited study of these compounds as possible chemotherapy enhancing agents against drug-sensitive tumors. We compared these agents as modifiers of VP-16 cytotoxicity in vitro and modifiers of VP-16 efficacy in vivo against drug-sensitive P388 and L1210 leukemias. Our study indicates that cyclosporin A enhances VP-16 cytotoxicity to a significantly greater extent than equimolar concentrations of verapamil or PSC-833. Although cremophor EL shows significantly greater activity than verapamil in VP-16 cytotoxicity enhancement in vitro, it is ineffective when added to VP-16 therapy of mice bearing L1210 leukemia.
AuthorsL Slater, P Sweet, M Wetzel, M Stupecky, K Osann
JournalLeukemia research (Leuk Res) Vol. 19 Issue 8 Pg. 543-8 (Aug 1995) ISSN: 0145-2126 [Print] ENGLAND
PMID7658700 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cyclosporins
  • valspodar
  • cremophor EL
  • Etoposide
  • Cyclosporine
  • Verapamil
  • Glycerol
Topics
  • Animals
  • Cell Survival (drug effects)
  • Cyclosporine (administration & dosage)
  • Cyclosporins (administration & dosage)
  • Drug Synergism
  • Etoposide (administration & dosage)
  • Glycerol (administration & dosage, analogs & derivatives)
  • Leukemia L1210
  • Leukemia P388
  • Mice
  • Survival Analysis
  • Tumor Cells, Cultured
  • Verapamil (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: